Post-colonoscopy upper gastrointestinal malignancies in positive immunochemical fecal occult blood test patients: An Australian data linkage study

Colonoscopy

Colorectal cancer incidence following a negative colonoscopy in fecal immunochemical test-based screening: a nationwide cohort study after 8 years of screening in Denmark

Endoscopy

Larsen PT, Jørgensen SF, Rasmussen M, Andersen B, Cross AJ, Njor SH

doi: 10.1055/a-2551-1471

ColonoscopyGastrointestinal Cancer

CT-colonography in Fecal Immunochemical Test Positives in a Colorectal Cancer Screening Program

Clin Gastroenterol Hepatol

Moen S, Marijnissen FE, Terhaar Sive Droste JS, de Vos Tot Nederveen Cappel WH, Spanier BWM, Huisman JF, Dekker E, Stoker J, Kuipers EJ, Thomeer MGJ, Spaander MCW, CT in BVO Study Group, Wolters LMM, Leeuwenburgh I, Tielemans MM, Vos XG, van Kouwen MCA, Kerkhof M, Schrauwen RWM, Veenstra RP, Capelle LG, Bigirwamungu-Bargeman M, Wientjes CA, van Enckevort C, Mulder SA, Cahen DL, Seerden TC, Gilissen LPL, Eichhorn R, Bus P, de Ridder RJJ, Buster EHCJ, van Nunen AB

doi: 10.1016/j.cgh.2025.03.009

ColonoscopyFurther Publications

Stool-based testing for post-polypectomy colorectal cancer surveillance safely reduces colonoscopies: The MOCCAS study

Gastroenterology

Carvalho B, de Klaver W, van Wifferen F, van Lanschot MCJ, van Wetering AJP, van der Zander QEW, Lemmens M, Bolijn AS, Tijssen M, Diemen PD, Buekers N, Daenen K, van der Meer J, van Mulligen PG, Hijmans BS, de Ridder S, Meiqari L, Bierkens M, van der Hulst RWM, Kuyvenhoven JPH, van Berkel AM, Depla ACTM, van Leerdam ME, Jansen JM, Wientjes CA, Straathof JA, Keulen ETP, Ramsoekh D, Moons LMG, Zacherl M, Masclee AAM, de Wit M, Greuter MJE, van Engeland M, Dekker E, Coupé VMH, Meijer GA

doi: 10.1053/j.gastro.2024.08.022

Colonoscopy

Choice of colon capsule or colonoscopy versus default colonoscopy in FIT positive patients in the Danish screening programme: a parallel group randomised controlled trial

Gut

Baatrup G, Bjørsum-Meyer T, Kaalby L, Schelde-Olesen B, Kobaek-Larsen M, Koulaouzidis A, Kroijer R, Al-Najami I, Buch N, Høgh A, Qvist N, Thygesen MK, Deding U, CareForColon2015 study group

doi: 10.1136/gutjnl-2024-333687

Gastrointestinal CancerFurther Publications

Harm-to-benefit ratio of fecal immunochemical test-based screening for colorectal cancer given prior fecal hemoglobin concentrations

Clin Gastroenterol Hepatol

Toes-Zoutendijk E, van de Schootbrugge-Vandermeer HJ, Katsara MA, de Jonge L, Spaander MCW, van Vuuren AJ, van Kemenade FJ, Dekker E, Nagtegaal ID, van Leerdam ME, Lansdorp-Vogelaar I, Meester RGS

doi: 10.1016/j.cgh.2024.08.041

Colonoscopy

Rebound in Fecal Testing, Colonoscopy Utilization, and Colorectal Neoplasia Detection During the COVID-19 Pandemic

Am J Gastroenterol

Langevin MJ, Jensen CD, Marks AR, Merchant SA, Badalov J, Lee JK, Lam AY, Halm EA, Levin TR

doi: 10.14309/ajg.0000000000003293

ColonoscopyGastrointestinal Cancer

Effect of invitation to colonoscopy versus faecal immunochemical test screening on colorectal cancer mortality (COLONPREV): a pragmatic, randomised, controlled, non-inferiority trial

Lancet

Castells A, Quintero E, Bujanda L, Castán-Cameo S, Cubiella J, Díaz-Tasende J, Lanas Á, Ono A, Serra-Burriel M, Frías-Arrocha E, Hernández C, Jover R, Andreu M, Carballo F, Morillas JD, Salas D, Almazán R, Alonso-Abreu I, Banales JM, Hernández V, Portillo I, Vanaclocha-Espí M, de la Vega M, COLONPREV study investigators

doi: 10.1016/S0140-6736(25)00145-X

Colonoscopy

Patient Navigation to Improve Colonoscopy Completion After an Abnormal Stool Test Result : A Randomized Controlled Trial

Ann Intern Med

Coronado GD, Petrik AF, Thompson JH, Leo MC, Slaughter M, Gautom P, Hussain SA, Mosso L, Gibbs J, Yadav N, Mummadi RR, Johnson ES, Jimenez R

doi: 10.7326/ANNALS-24-01885

ColonoscopyGastrointestinal Cancer

A predictive model based on quantitative fecal immunochemical test can stratify the risk of CRC in an organized screening program

Clin Gastroenterol Hepatol

Frazzoni L, Pecere S, Hassan C, Fuccio L, Del Vecchio LE, Fabbri C, Arrigoni A, Cassoni P, Mazzucco D, Orione L, Gibiino G, Repici A, Spada C, Iacopini F, Senore C, Antonelli G

doi: 10.1016/j.cgh.2024.09.036

Related content

Colorectal cancer incidence following a negative colonoscopy in fecal immunochemical test-based screening: a nationwide cohort study after 8 years of screening in Denmark

CT-colonography in Fecal Immunochemical Test Positives in a Colorectal Cancer Screening Program

Stool-based testing for post-polypectomy colorectal cancer surveillance safely reduces colonoscopies: The MOCCAS study

Choice of colon capsule or colonoscopy versus default colonoscopy in FIT positive patients in the Danish screening programme: a parallel group randomised controlled trial

Harm-to-benefit ratio of fecal immunochemical test-based screening for colorectal cancer given prior fecal hemoglobin concentrations

Rebound in Fecal Testing, Colonoscopy Utilization, and Colorectal Neoplasia Detection During the COVID-19 Pandemic

Effect of invitation to colonoscopy versus faecal immunochemical test screening on colorectal cancer mortality (COLONPREV): a pragmatic, randomised, controlled, non-inferiority trial

Patient Navigation to Improve Colonoscopy Completion After an Abnormal Stool Test Result : A Randomized Controlled Trial

A predictive model based on quantitative fecal immunochemical test can stratify the risk of CRC in an organized screening program